HLLI achieved a First Amendment victory Friday by securing Alabama Attorney General Steven Marshall’s commitment that its client Christopher Kohls’s artificial intelligence generated political parody falls outside the scope of the recently based HB 172.
HLLI, representing two non-profit nursing homes and state affiliates, filed a lawsuit challenging the legality of a federal regulation by the Centers for Medicare & Medicaid Services (CMS) that threatens the health, safety, and well-being of millions of nursing home patients across the county.
HLLI secured a major victory—a preliminary injunction—in its lawsuit against California’s new laws that threaten to restrict AI-generated political satire.
HLLI and Upper Midwest Law Center filed a lawsuit challenging the constitutionality of Minnesota's law, § 609.771, which bans AI-generated political satire.
The Hamilton Lincoln Law Institute (HLLI), a public interest law firm, is suing California officials on behalf of “Mr Reagan,” a YouTuber who creates political satire videos.
HLLI filed a lawsuit concerning the April 15, 2024 blockade of the main entrance into O’Hare International Airport in Chicago, It defends the rights of citizens unlawfully impeded by anti-Israel, pro-Gaza groups engaging in illegal acts of obstruction.
HLLI petitioned a federal appeals court to recognize a high school student's off-campus social media post as protected speech under the First Amendment, challenging the school district’s disciplinary actions.
HLLI filed a joint comment letter on behalf of Scott Alexander of Astral Codex Ten, Maxim Lott, the operator of ElectionBettingOdds.com, and Theodore H. Frank against a proposed CFTC rule, which would categorically ban all prediction markets for political elections, equating such markets with “gambling.”
June 28, 2024 — FOR IMMEDIATE RELEASE Washington D.C. — On Friday, the Hamilton Lincoln Law Institute (HLLI) asked a federal court to make permanent its earlier ruling stopping Missouri’s unconstitutional restriction of the speech of Missouri pharmacists. The law at issue, § 338.055.7, RSMo., prevents pharmacists in the state from communicating with physicians or patients to dispute the effectiveness of ivermectin or hydroxychloroquine for human use as a COVID-19 treatment. Representing…
HLLI filed an amicus brief challenging the SEC’s new regulation requiring publicly traded companies to make climate-related disclosures in securities filings.